Frontiers:注意你的糖化!我国学者发现糖化升高影响冠心病支架植入结果!

2022-01-11 MedSci原创 MedSci原创

斑块脆弱性的增加和更高的脂质变异性是不良心血管事件的原因。

斑块脆弱性的增加和更高的脂质变异性是不良血管事件的原因。尽管葡萄糖和脂质代谢密切相关,但糖化血红蛋白A1c(HbA1c)升高对斑块脆弱性和脂质变异性的影响仍不清楚。为此,我国福建医科大学和浙江大学的心血管专家开展了相关研究,结果发表在Frontiers in Cardiology Medicine杂志上。

在2009年至2019年接受经皮冠状动脉介入治疗(PCI)的受试者中,366名患者接受了血管内光学相干断层扫描(OCT)评估,4445名患者在PCI后1年内进行了预定的随访。通过OCT检查分析了罪魁祸首血管的脆弱性特征,包括评估脂质、巨噬细胞、钙质和最小纤维帽厚度(FCT)。

通过不同的定义,包括标准差(SD)、变异系数(CV)和独立于平均值的变异性(VIM),来确定各次访问的血脂变异性。多变量线性回归分析被用来验证HbA1c对斑块脆弱性特征和血脂变异性的影响。对非糖尿病患者也进行了探索性分析。

结果显示,在入选的受试者中,术前HbA1c为5.90±1.31%,平均随访HbA1c为5.98±1.16%。通过OCT评估,多变量线性回归分析表明,HbA1c升高的患者最小FCT更薄(β=-6.985,P=0.048),脂质指数(LI)更大(β=226.299,P=0.005),巨噬细胞指数更高(β=54.526,P=0.045),提示斑块易损易破裂。

即使在非糖尿病患者中,HbA1c的升高也会线性地降低最小FCT(β=-14.011,P=0.036),增加LI(β=290.048,P=0.041)和巨噬细胞指数(β=120.029,P=0.048)。

随后,在PCI术后1年内进行了定期随访。多变量线性回归分析证明,平均随访HbA1c水平的升高会增加血脂谱的VIM,包括低密度脂蛋白胆固醇(β=2.594,P<0. 001),高密度脂蛋白胆固醇(β=0.461,P=0.044),非高密度脂蛋白胆固醇(β=1.473,P<0.001),总胆固醇(β=0.947,P<0.001),和甘油三酯(β=4.217,P<0.001)。这一结果在非糖尿病患者中是一致的,当用SD和CV来估计变异性时也得到了验证。

由此可见,在接受选择性PCI的患者中,HbA1c的升高会增加动脉粥样硬化斑块的脆弱性和血脂谱的逐次变化,且该结果在非糖尿病患者仍可靠。

 

参考文献:

Elevation of Hemoglobin A1c Increases the Atherosclerotic Plaque Vulnerability and the Visit-to-visit Variability of Lipid Profiles in Patients Who Underwent Elective Percutaneous Coronary Intervention

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-03-19 anminleiryan
  3. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-01-13 jiyangfei
  5. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-01-12 屋顶瞄爱赏月

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2070626, encodeId=2cb320e0626e3, content=<a href='/topic/show?id=a13a54112f5' target=_blank style='color:#2F92EE;'>#我国学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54112, encryptionId=a13a54112f5, topicName=我国学者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=743b215, createdName=fusion, createdTime=Wed Jun 22 22:16:05 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878453, encodeId=d1c818e8453d1, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Mar 19 03:16:05 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935176, encodeId=e96b19351e6c9, content=<a href='/topic/show?id=49455e1086e' target=_blank style='color:#2F92EE;'>#支架植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57108, encryptionId=49455e1086e, topicName=支架植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Dec 17 19:16:05 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520788, encodeId=4ced1520e885b, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Thu Jan 13 10:16:05 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183629, encodeId=b37011836291e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 12 20:19:14 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183390, encodeId=d9ed1183390ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65846460968, createdName=ms6000001134119511, createdTime=Tue Jan 11 23:04:04 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-01-11 ms6000001134119511

    学习了

    0

相关资讯

NEJM:搭桥 or 支架?冠心病患者的选择因病情而异!

在三血管冠状动脉疾病患者中,就死亡、心肌梗死、中风或1年后重复血管治疗的发生率而言,FFR引导下的PCI并不劣于CABG。

Eur Heart J:接受PCI的高出血风险患者替格瑞洛单药治疗效果分析

在完成3个月DAPT且未出现重大不良事件的接受PCI的HBR患者中,与替格瑞洛联合阿司匹林治疗相比,停用阿司匹林后进行替格瑞洛单药治疗可显著减少出血,而不会增加缺血事件。

NEJM:高出血风险患者PCI后双重抗血小板治疗

就净不良临床事件和主要不良心脏或大脑事件的发生情况而言,1个月的双重抗血小板治疗不劣于2个月以上的持续治疗;缩短治疗可使大出血或临床相关的非大出血发生率降低。

EHJ:孰优孰略?冠脉三支病变或左主干病变患者介入与开胸手术的比较

在3VD和/或LMCAD患者中,MAG可能是更理想的CABG配置,以实现比PCI更低的长期全因死亡率。

EHJ:我国学者:糖尿病合并冠心病患者PCI与CABG手术疗效死亡率相当!

心血管疾病(CVD)是糖尿病最主要的合并症,影响着近三分之一的患者。

Lancet:阜外医院:定量流量比指导的病变选择策略能明显改善PCI术后患者的临床结局

在接受PCI的患者中,与标准血管造影指导相比,QFR指导的病变选择策略改善了1年的临床结果。

拓展阅读

每10例糖尿病人中就有2例!这种情况下,该并发症进展与血糖降太快无关

结果显示,HbA1c的快速降低与轻度或中度NPDR的进展无关。

10万中国人研究数据:经常陪打工人下班的ta,竟可升高28%糖尿病发生风险!

Diabetologia:夜间户外光线与中国成年人血糖稳态和糖尿病的关系:一项来自162个研究地点的98658名参与者的全国性横断面研究

JAMA Netw Open:管理糖尿病,“用真心就可以吗”?家庭支持干预真心可以!

JAMA Netw Open:对患者-家庭二元组进行健康指导干预以改善成人糖尿病患者结局的有效性一项随机临床试验

JGIM:内分泌会诊可增加口服降糖药的“处方率”,HbA1c控制不佳的患者可考虑!

对控制不良的2型糖尿病患者进行内分泌科专科会诊是可行的,主动会诊与降糖药物处方增加相关,虽然与匹配对照相比,它并没有导致HbA1c的临床显著下降。

JACC:高血糖大大推进亚临床心衰的进展!

在亚临床心衰的老年人中,控制不佳的糖尿病与心衰进展的高风险密切相关

Diabetes Care:不论胖瘦、有无微血管疾病,杜拉鲁肽都能降低HbA1c

杜拉鲁肽1.5毫克的治疗与72个月内HbA1c的长期下降有统计学关系,且该作用与基线糖尿病持续时间、微血管疾病和BMI无关。